Report Detail

Request for Sample of this report

Medical Industry Global Covid-19 Vaccine Market Size, Status and Forecast 2020-2026

  • RnM3940377
    • |
  • 27 March, 2020
    • |
  • Global
    • |
  • 128 Pages
    • |
  • QYResearch
    • |
  • Medical Industry

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Covid-19 Vaccine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Covid-19 Vaccine market in terms of revenue.
Players, stakeholders, and other participants in the global Covid-19 Vaccine market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global Covid-19 Vaccine market, covering important regions, viz, North America, Europe, China, Japan, South Korea, Middle East, Southeast Asia and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.
Competition Analysis
In the competitive analysis section of the report, leading as well as prominent players of the global Covid-19 Vaccine market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Covid-19 Vaccine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Covid-19 Vaccine market.
The following players are covered in this report:
Inovio Pharmaceuticals
Takis Biotech (Evvivax)
Zydus Cadila
Codagenix, Inc.
GeoVax, Inc.
Bravovax
Janssen Pharmaceutical Companies
Altimmune
Vaxart
CanSino Biologics
ExpreS2ion Biotechnologies ApS
Clover Biopharmaceuticals
GSK
Vaxil Bio Ltd.
Generex
Novavax, Inc.
Sanofi Pasteur
Baylor
iBio, Inc.
Zydus Cadila
Moderna, Inc.
Curevac
ImmunoPrecise
Covid-19 Vaccine Breakdown Data by Type
DNA
Live Attenuated Virus
NonReplicating Viral Vecto
Protein Subunit
RNA
Covid-19 Vaccine Breakdown Data by Application
Treatment
Prevention


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered: Ranking by Covid-19 Vaccine Revenue
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Covid-19 Vaccine Market Size Growth Rate by Type: 2020 VS 2026
      • 1.4.2 DNA
      • 1.4.3 Live Attenuated Virus
      • 1.4.4 NonReplicating Viral Vecto
      • 1.4.5 Protein Subunit
      • 1.4.6 RNA
    • 1.5 Market by Application
      • 1.5.1 Global Covid-19 Vaccine Market Share by Application: 2020 VS 2026
      • 1.5.2 Treatment
      • 1.5.3 Prevention
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends by Regions

    • 2.1 Covid-19 Vaccine Market Perspective (2015-2026)
    • 2.2 Covid-19 Vaccine Growth Trends by Regions
      • 2.2.1 Covid-19 Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
      • 2.2.2 Covid-19 Vaccine Historic Market Share by Regions (2015-2020)
      • 2.2.3 Covid-19 Vaccine Forecasted Market Size by Regions (2021-2026)
    • 2.3 Industry Trends and Growth Strategy
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis
      • 2.3.5 Covid-19 Vaccine Market Growth Strategy
      • 2.3.6 Primary Interviews with Key Covid-19 Vaccine Players (Opinion Leaders)

    3 Competition Landscape by Key Players

    • 3.1 Global Top Covid-19 Vaccine Players by Market Size
      • 3.1.1 Global Top Covid-19 Vaccine Players by Revenue (2015-2020)
      • 3.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2015-2020)
      • 3.1.3 Global Covid-19 Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 3.2 Global Covid-19 Vaccine Market Concentration Ratio
      • 3.2.1 Global Covid-19 Vaccine Market Concentration Ratio (CR5 and HHI)
      • 3.2.2 Global Top 10 and Top 5 Companies by Covid-19 Vaccine Revenue in 2019
    • 3.3 Covid-19 Vaccine Key Players Head office and Area Served
    • 3.4 Key Players Covid-19 Vaccine Product Solution and Service
    • 3.5 Date of Enter into Covid-19 Vaccine Market
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type (2015-2026)

    • 4.1 Global Covid-19 Vaccine Historic Market Size by Type (2015-2020)
    • 4.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2021-2026)

    5 Covid-19 Vaccine Breakdown Data by Application (2015-2026)

    • 5.1 Global Covid-19 Vaccine Market Size by Application (2015-2020)
    • 5.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2021-2026)

    6 North America

    • 6.1 North America Covid-19 Vaccine Market Size (2015-2020)
    • 6.2 Covid-19 Vaccine Key Players in North America (2019-2020)
    • 6.3 North America Covid-19 Vaccine Market Size by Type (2015-2020)
    • 6.4 North America Covid-19 Vaccine Market Size by Application (2015-2020)

    7 Europe

    • 7.1 Europe Covid-19 Vaccine Market Size (2015-2020)
    • 7.2 Covid-19 Vaccine Key Players in Europe (2019-2020)
    • 7.3 Europe Covid-19 Vaccine Market Size by Type (2015-2020)
    • 7.4 Europe Covid-19 Vaccine Market Size by Application (2015-2020)

    8 China

    • 8.1 China Covid-19 Vaccine Market Size (2015-2020)
    • 8.2 Covid-19 Vaccine Key Players in China (2019-2020)
    • 8.3 China Covid-19 Vaccine Market Size by Type (2015-2020)
    • 8.4 China Covid-19 Vaccine Market Size by Application (2015-2020)

    9 Japan

    • 9.1 Japan Covid-19 Vaccine Market Size (2015-2020)
    • 9.2 Covid-19 Vaccine Key Players in Japan (2019-2020)
    • 9.3 Japan Covid-19 Vaccine Market Size by Type (2015-2020)
    • 9.4 Japan Covid-19 Vaccine Market Size by Application (2015-2020)

    10 South Korea

    • 10.1 South Korea Covid-19 Vaccine Market Size (2015-2020)
    • 10.2 Covid-19 Vaccine Key Players in South Korea (2019-2020)
    • 10.3 South Korea Covid-19 Vaccine Market Size by Type (2015-2020)
    • 10.4 South Korea Covid-19 Vaccine Market Size by Application (2015-2020)

    11 Middle East

    • 11.1 Middle East Covid-19 Vaccine Market Size (2015-2020)
    • 11.2 Covid-19 Vaccine Key Players in Middle East (2019-2020)
    • 11.3 Middle East Covid-19 Vaccine Market Size by Type (2015-2020)
    • 11.4 Middle East Covid-19 Vaccine Market Size by Application (2015-2020)

    12 Southeast Asia

    • 12.1 Southeast Asia Covid-19 Vaccine Market Size (2015-2020)
    • 12.2 Covid-19 Vaccine Key Players in Southeast Asia (2019-2020)
    • 12.3 Southeast Asia Covid-19 Vaccine Market Size by Type (2015-2020)
    • 12.4 Southeast Asia Covid-19 Vaccine Market Size by Application (2015-2020)

    13 Central & South America

    • 13.1 Central & South America Covid-19 Vaccine Market Size (2015-2020)
    • 13.2 Covid-19 Vaccine Key Players in Central & South America (2019-2020)
    • 13.3 Central & South America Covid-19 Vaccine Market Size by Type (2015-2020)

    .4 Central & South America Covid-19 Vaccine Market Size by Application (2015-2020)

      14 Key Players Profiles

      • 14.1 Inovio Pharmaceuticals
        • 14.1.1 Inovio Pharmaceuticals Company Details
        • 14.1.2 Inovio Pharmaceuticals Business Overview and Its Total Revenue
        • 14.1.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
        • 14.1.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2015-2020))
        • 14.1.5 Inovio Pharmaceuticals Recent Development
      • 14.2 Takis Biotech (Evvivax)
        • 14.2.1 Takis Biotech (Evvivax) Company Details
        • 14.2.2 Takis Biotech (Evvivax) Business Overview and Its Total Revenue
        • 14.2.3 Takis Biotech (Evvivax) Covid-19 Vaccine Introduction
        • 14.2.4 Takis Biotech (Evvivax) Revenue in Covid-19 Vaccine Business (2015-2020)
        • 14.2.5 Takis Biotech (Evvivax) Recent Development
      • 14.3 Zydus Cadila
        • 14.3.1 Zydus Cadila Company Details
        • 14.3.2 Zydus Cadila Business Overview and Its Total Revenue
        • 14.3.3 Zydus Cadila Covid-19 Vaccine Introduction
        • 14.3.4 Zydus Cadila Revenue in Covid-19 Vaccine Business (2015-2020)
        • 14.3.5 Zydus Cadila Recent Development
      • 14.4 Codagenix, Inc.
        • 14.4.1 Codagenix, Inc. Company Details
        • 14.4.2 Codagenix, Inc. Business Overview and Its Total Revenue
        • 14.4.3 Codagenix, Inc. Covid-19 Vaccine Introduction
        • 14.4.4 Codagenix, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
        • 14.4.5 Codagenix, Inc. Recent Development
      • 14.5 GeoVax, Inc.
        • 14.5.1 GeoVax, Inc. Company Details
        • 14.5.2 GeoVax, Inc. Business Overview and Its Total Revenue
        • 14.5.3 GeoVax, Inc. Covid-19 Vaccine Introduction
        • 14.5.4 GeoVax, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
        • 14.5.5 GeoVax, Inc. Recent Development
      • 14.6 Bravovax
        • 14.6.1 Bravovax Company Details
        • 14.6.2 Bravovax Business Overview and Its Total Revenue
        • 14.6.3 Bravovax Covid-19 Vaccine Introduction
        • 14.6.4 Bravovax Revenue in Covid-19 Vaccine Business (2015-2020)
        • 14.6.5 Bravovax Recent Development
      • 14.7 Janssen Pharmaceutical Companies
        • 14.7.1 Janssen Pharmaceutical Companies Company Details
        • 14.7.2 Janssen Pharmaceutical Companies Business Overview and Its Total Revenue
        • 14.7.3 Janssen Pharmaceutical Companies Covid-19 Vaccine Introduction
        • 14.7.4 Janssen Pharmaceutical Companies Revenue in Covid-19 Vaccine Business (2015-2020)
        • 14.7.5 Janssen Pharmaceutical Companies Recent Development
      • 14.8 Altimmune
        • 14.8.1 Altimmune Company Details
        • 14.8.2 Altimmune Business Overview and Its Total Revenue
        • 14.8.3 Altimmune Covid-19 Vaccine Introduction
        • 14.8.4 Altimmune Revenue in Covid-19 Vaccine Business (2015-2020)
        • 14.8.5 Altimmune Recent Development
      • 14.9 Vaxart
        • 14.9.1 Vaxart Company Details
        • 14.9.2 Vaxart Business Overview and Its Total Revenue
        • 14.9.3 Vaxart Covid-19 Vaccine Introduction
        • 14.9.4 Vaxart Revenue in Covid-19 Vaccine Business (2015-2020)
        • 14.9.5 Vaxart Recent Development
      • 14.10 CanSino Biologics
        • 14.10.1 CanSino Biologics Company Details
        • 14.10.2 CanSino Biologics Business Overview and Its Total Revenue
        • 14.10.3 CanSino Biologics Covid-19 Vaccine Introduction
        • 14.10.4 CanSino Biologics Revenue in Covid-19 Vaccine Business (2015-2020)
        • 14.10.5 CanSino Biologics Recent Development
      • 14.11 ExpreS2ion Biotechnologies ApS
        • 10.11.1 ExpreS2ion Biotechnologies ApS Company Details
        • 10.11.2 ExpreS2ion Biotechnologies ApS Business Overview and Its Total Revenue
        • 10.11.3 ExpreS2ion Biotechnologies ApS Covid-19 Vaccine Introduction
        • 10.11.4 ExpreS2ion Biotechnologies ApS Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.11.5 ExpreS2ion Biotechnologies ApS Recent Development
      • 14.12 Clover Biopharmaceuticals
        • 10.12.1 Clover Biopharmaceuticals Company Details
        • 10.12.2 Clover Biopharmaceuticals Business Overview and Its Total Revenue
        • 10.12.3 Clover Biopharmaceuticals Covid-19 Vaccine Introduction
        • 10.12.4 Clover Biopharmaceuticals Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.12.5 Clover Biopharmaceuticals Recent Development
      • 14.13 GSK
        • 10.13.1 GSK Company Details
        • 10.13.2 GSK Business Overview and Its Total Revenue
        • 10.13.3 GSK Covid-19 Vaccine Introduction
        • 10.13.4 GSK Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.13.5 GSK Recent Development
      • 14.14 Vaxil Bio Ltd.
        • 10.14.1 Vaxil Bio Ltd. Company Details
        • 10.14.2 Vaxil Bio Ltd. Business Overview and Its Total Revenue
        • 10.14.3 Vaxil Bio Ltd. Covid-19 Vaccine Introduction
        • 10.14.4 Vaxil Bio Ltd. Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.14.5 Vaxil Bio Ltd. Recent Development
      • 14.15 Generex
        • 10.15.1 Generex Company Details
        • 10.15.2 Generex Business Overview and Its Total Revenue
        • 10.15.3 Generex Covid-19 Vaccine Introduction
        • 10.15.4 Generex Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.15.5 Generex Recent Development
      • 14.16 Novavax, Inc.
        • 10.16.1 Novavax, Inc. Company Details
        • 10.16.2 Novavax, Inc. Business Overview and Its Total Revenue
        • 10.16.3 Novavax, Inc. Covid-19 Vaccine Introduction
        • 10.16.4 Novavax, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.16.5 Novavax, Inc. Recent Development
      • 14.17 Sanofi Pasteur
        • 10.17.1 Sanofi Pasteur Company Details
        • 10.17.2 Sanofi Pasteur Business Overview and Its Total Revenue
        • 10.17.3 Sanofi Pasteur Covid-19 Vaccine Introduction
        • 10.17.4 Sanofi Pasteur Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.17.5 Sanofi Pasteur Recent Development
      • 14.18 Baylor
        • 10.18.1 Baylor Company Details
        • 10.18.2 Baylor Business Overview and Its Total Revenue
        • 10.18.3 Baylor Covid-19 Vaccine Introduction
        • 10.18.4 Baylor Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.18.5 Baylor Recent Development
      • 14.19 iBio, Inc.
        • 10.19.1 iBio, Inc. Company Details
        • 10.19.2 iBio, Inc. Business Overview and Its Total Revenue
        • 10.19.3 iBio, Inc. Covid-19 Vaccine Introduction
        • 10.19.4 iBio, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.19.5 iBio, Inc. Recent Development
      • 14.20 Zydus Cadila
        • 10.20.1 Zydus Cadila Company Details
        • 10.20.2 Zydus Cadila Business Overview and Its Total Revenue
        • 10.20.3 Zydus Cadila Covid-19 Vaccine Introduction
        • 10.20.4 Zydus Cadila Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.20.5 Zydus Cadila Recent Development
      • 14.21 Moderna, Inc.
        • 10.21.1 Moderna, Inc. Company Details
        • 10.21.2 Moderna, Inc. Business Overview and Its Total Revenue
        • 10.21.3 Moderna, Inc. Covid-19 Vaccine Introduction
        • 10.21.4 Moderna, Inc. Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.21.5 Moderna, Inc. Recent Development
      • 14.22 Curevac
        • 10.22.1 Curevac Company Details
        • 10.22.2 Curevac Business Overview and Its Total Revenue
        • 10.22.3 Curevac Covid-19 Vaccine Introduction
        • 10.22.4 Curevac Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.22.5 Curevac Recent Development
      • 14.23 ImmunoPrecise
        • 10.23.1 ImmunoPrecise Company Details
        • 10.23.2 ImmunoPrecise Business Overview and Its Total Revenue
        • 10.23.3 ImmunoPrecise Covid-19 Vaccine Introduction
        • 10.23.4 ImmunoPrecise Revenue in Covid-19 Vaccine Business (2015-2020)
        • 10.23.5 ImmunoPrecise Recent Development

      15 Analyst's Viewpoints/Conclusions

        16 Appendix

        • 16.1 Research Methodology
          • 16.1.1 Methodology/Research Approach
          • 16.1.2 Data Source
        • 16.2 Disclaimer

        Summary:
        Get latest Market Research Reports on Covid-19 Vaccine. Industry analysis & Market Report on Covid-19 Vaccine is a syndicated market report, published as Global Covid-19 Vaccine Market Size, Status and Forecast 2020-2026. It is complete Research Study and Industry Analysis of Covid-19 Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

        Last updated on

        REPORT YOU MIGHT BE INTERESTED

        Purchase this Report

        		$3,500.00
        		$7,000.00
        		2,705.50
        		5,411.00
        		3,258.50
        		6,517.00
        		534,415.00
        		1,068,830.00
        		295,400.00
        		590,800.00
        Credit card Logo
        Sample Question Discount Download PDF

        Related Reports

        Reason to Buy

        • Trusted By Leaders

          Top executives from leading companies purchase research reports from us. 

        • Shop With Confidence

          We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

        • Customer Centric

          Need assistance related to your research requirements? We are just a phone call or an email away.

        • Personalized Solutions

          Our experienced research specialists are here to help you locate the right reports for your need.

        • Secure Checkout

          Shop without being worried about safety & security of your transactions.
          •

        Request for Sample of this report

        Reports and Markets

        mcafree

        Contact Us

        +1-352-353-0818 (US)

        info@reportsandmarkets.com

        Support

        EMAIL US

        Newsletter

        KEEP UP TO DATE ON ALL THE LATEST REPORTS


        maxmind_logo